Ramakrishna Edupuganti

Ramakrishna Edupuganti

University of Texas Austin - Austin / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 1676812
University of Texas at Austin
person_outline Ramakrishna Edupuganti's MOST POPULAR ARTICLES
1-) c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-JunX Xie, TS Kaoud, R Edupuganti, T Zhang, T Kogawa, Y Zhao, ...Oncogene 36 (18), 2599-2608, 2017652017
2-) Synthesis and biological evaluation of pyrido [2, 3-d] pyrimidine-2, 4-dione derivatives as eEF-2K inhibitorsR Edupuganti, Q Wang, CDJ Tavares, CA Chitjian, JL Bachman, P Ren, ...Bioorganic & medicinal chemistry 22 (17), 4910-4916, 2014752014
3-) Definition of a novel feed-forward mechanism for glycolysis-HIF1α signaling in hypoxic tumors highlights aldolase A as a therapeutic targetG Grandjean, PR de Jong, BP James, MY Koh, R Lemos, J Kingston, ...Cancer research 76 (14), 4259-4269, 2016742016
4-) Asymmetric Total Synthesis of (S)-(+)-Cocaine and the First Synthesis of Cocaine C-1 Analogs from N-Sulfinyl β-Amino Ester KetalsFA Davis, N Theddu, R EdupugantiOrganic letters 12 (18), 4118-4121, 2010532010
5-) Conformational preferences of substrates for human prolyl 4-hydroxylaseKL Gorres, R Edupuganti, GR Krow, RT RainesBiochemistry 47 (36), 9447-9455, 2008492008